Owners and Funding

Owners
Redoxis is a privately held company owned by its founders, personnel and the investment firm Sätila MedTech AB .

EU Funding
A significant part of Redoxis’ research and development is funded by support from EU framework programs like the integrated Fp6 programs AUTOCURE and NeuroproMiSe and the FP7 program Masterswitch (www.masterswitchproject.eu) and NeuriNox. With the partnership in EU funded framework programs, we are able to participate in networks including cutting edge researchers from Europe’s main Universities, clinical centers and the pharma industry.